Status:
UNKNOWN
Antibiotic Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty
Lead Sponsor:
The Norwegian Arthroplasty Register
Collaborating Sponsors:
Helse Vest
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Introduction: The current evidence on the efficacy of Antibiotic Loaded Bone Cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insuffici...
Eligibility Criteria
Inclusion
- all patients undergoing full-cemented primary TKA irrespective of the diagnosis leading to TKA
Exclusion
- any history of infection in the knee, a need for fully stabilized or hinged TKA, a history of allergy to the antibiotics used in the cement, inability or not willing to consent for inclusion in NAR or the trial, and participation in other studies that might have pharmacological interaction with this trial.
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
9172 Patients enrolled
Trial Details
Trial ID
NCT04135170
Start Date
January 14 2021
End Date
December 31 2025
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Orthopeadic Surgery, Haukeland University Hospital
Bergen, Norway